Shandong Qilu Stem Cells Engineering Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Shandong Qilu Stem Cells Engineering Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression . (NCT07201233) | Shandong Qilu Stem Cells Engineering Co., Ltd. | 2025-11-01 |
| Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders (NCT05794425) | Shandong Qilu Stem Cells Engineering Co., Ltd. | 2023-08-01 |
| Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases (NCT06427642) | Shandong Qilu Stem Cells Engineering Co., Ltd. | 2022-04-01 |
| Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis (NCT04882683) | Shandong Qilu Stem Cells Engineering Co., Ltd. | 2021-06-01 |
| Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis (NCT03529136) | Shandong Qilu Stem Cells Engineering Co., Ltd. | 2018-06-01 |
Track Shandong Qilu Stem Cells Engineering Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.